Halo Active Aromatic Sulfonamide Compositions for Drug-Resistant Infections
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current treatments for infections, such as bacterial, viral, and fungal infections, are often ineffective against drug-resistant pathogens, and existing pharmaceuticals may not provide immediate and certain treatment options, especially for infections that have become resistant to traditional antibiotics.
Innovation Solution
Compositions comprising halo active aromatic sulfonamide compounds, which can be administered internally or externally, offering broad-spectrum antimicrobial activity and prolonged disinfectant effects, are used to treat and prevent infections, including those resistant to traditional pharmaceuticals, through various administration methods and delivery devices.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If traditional antibiotics and antivirals are used, then treatment is effective against susceptible pathogens, but treatment fails against drug-resistant pathogens
Solution Approach 1:
The patent applies universality by designing a single pharmaceutical composition that can treat multiple types of infections (bacterial, viral, fungal) simultaneously. The composition includes broad-spectrum antimicrobial agents that are effective against both susceptible and drug-resistant pathogens, eliminating the need to select different medications for different pathogens.
Solution Approach 2:
The patent employs parameter changes by modifying the chemical structure of sulfonamide compounds to create halo-active derivatives with enhanced antimicrobial activity. The systematic variation of substituents (halogen atoms at different positions, various R groups) allows optimization of both efficacy against resistant strains and safety profile.
2Reliability
If broad-spectrum antimicrobial agents are used, then coverage against resistant pathogens is improved, but harmful effects on human tissues may increase
Solution Approach 1:
The patent applies local quality by carefully selecting specific halogen substitutions at particular positions on the aromatic ring, which creates localized electronic effects that enhance antimicrobial activity at the target site while maintaining safety. The specific configuration of substituents (e.g., chlorine at position 2, fluorine at position 4) provides selective enhancement of efficacy without proportionally increasing toxicity.
Solution Approach 2:
The patent uses composite materials by combining multiple components in a single formulation: halo-active sulfonamide compounds, antioxidants, buffering agents, and stabilizers. This composite approach allows the active antimicrobial agents to work effectively while the other components mitigate potential harmful effects and improve overall safety and stability of the composition.
Data Source
AI summary
Disclosed herein are compositions useful for the treatment and/or prevention of various diseases and conditions, including a variety of infections, via internal administration to a patient. The compositions comprise an effective amount of a halo active aromatic sulfonamide compound having the structure of Formula (I):wherein R1, R2, R3, R4, and R5, X, and M are defined herein. The compositions described may be used to treat and/or prevent a variety of infections, including bacterial infections, viral infections, fungal infections, and the like. The compositions can be internally administered to a patient via at least one of: oral administration, pulmonary administration, subcutaneous administration, sublingual administration, ocular administration, otic administration, intravenous administration, inter-dermal administration, epidural administration, intraperitoneal administration, and intramuscular administration.